Genprex, Inc. (GNPX)
$2.51-6.69%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- -0.97
- P/E (TTM)
- -0.02
- Short % float
- 20.21%
- Days to cover
- 1.0
- SI change
- +17.3%
- 1W
- -3.83%
- 1M
- -27.25%
- vs SPY 1W
- -3.69%
- vs SPY 1M
- -29.75%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GNPX?
- LOPJLB’s latest quantitative signal on Genprex, Inc. (GNPX) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is GNPX in?
- Genprex, Inc. (GNPX) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Genprex, Inc. (GNPX) do?
- Genprex, Inc. is a biotechnology firm specializing in gene therapy, with its primary focus on advancing treatments through clinical stages. Their mission revolves around developing innovative therapies for patients battling cancer and diabetes. Leading their product pipeline is REQORSA (GPX-001), a flagship gene therapy candidate specifically designed to target both non-small cell lung cancer a…